AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/23/2024 | Press release | Distributed by Public on 05/23/2024 10:34
Please select the service you want to use:
Smartlinks | Econocom Group SE | News | Securities Issuers | IT Service Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Stuttgart Stock Exchange | Euronext Bruxelles | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Aquis Exchange | SIGMA X MTF | Cinnober BOAT | Equiduct | Euronext Block MTF | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact